Additionally, next-generation sequencing of CSF has been found to be superior to peripheral blood-based genetic testing at identifying uncommon EGFR mutation in NSCLC patients with leptomeningeal metastases [180]. Here, EGFR is linked to non-small cell lung carcinoma.